Inventor
GRAY NATHANAEL S
US141 patents
⚠️ This page may combine multiple inventors who share the name “GRAY NATHANAEL S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
27 patentsUS10550121B2Feb 4, 2020
Inhibitors of cyclin-dependent kinases
DANA FARBER CANCER INST INC15 citations94
US9862688B2Jan 9, 2018
Hydrophobically tagged janus kinase inhibitors and uses thereof
DANA FARBER CANCER INST INC22 citations94
US9676792B2Jun 13, 2017
Pyrimido-diazepinone compounds and methods of treating disorders
DANA FARBER CANCER INST INC12 citations91
US11325910B2May 10, 2022
Inhibitors of cyclin-dependent kinases
DANA FARBER CANCER INST INC8 citations86
US10017477B2Jul 10, 2018
Janus kinase inhibitors and uses thereof
DANA FARBER CANCER INST INC20 citations86
US11306070B2Apr 19, 2022
Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof
DANA FARBER CANCER INST INC8 citations84
US10975058B2Apr 13, 2021
Imidazolyl kinase inhibitors and uses thereof
DANA FARBER CANCER INST INC6 citations84
US10870651B2Dec 22, 2020
Inhibitors of cyclin-dependent kinase 7 (CDK7)
DANA FARBER CANCER INST INC9 citations84
US10457691B2Oct 29, 2019
Macrocyclic kinase inhibitors and uses thereof
DANA FARBER CANCER INST INC9 citations84
US10287268B2May 14, 2019
Imidazolyl kinase inhibitors and uses thereof
DANA FARBER CANCER INST INC11 citations84
US9464091B2Oct 11, 2016
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
DANA FARBER CANCER INST INC5 citations84
US10265321B2Apr 23, 2019
Uses of salt-inducible kinase (SIK) inhibitors
DANA FARBER CANCER INST INC10 citations83
US10112957B2Oct 30, 2018
Thiazolyl-containing compounds for treating proliferative diseases
DANA FARBER CANCER INST INC5 citations83
US9908872B2Mar 6, 2018
Methods to treat lymphoplasmacytic lymphoma
DANA FARBER CANCER INST INC6 citations83
US9856223B2Jan 2, 2018
Methods to treat lymphoplasmacytic lymphoma
DANA FARBER CANCER INST INC6 citations83
US9695172B2Jul 4, 2017
Diazepane derivatives and uses thereof
DANA FARBER CANCER INST INC13 citations83
US10233157B2Mar 19, 2019
SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder
DANA FARBER CANCER INST INC9 citations82
US10925967B2Feb 23, 2021
Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand and methods of use
DANA FARBER CANCER INST INC4 citations81
US12098154B2Sep 24, 2024
Inhibitors of cyclin-dependent kinases
DANA FARBER CANCER INST INC1 citations73
US11932625B2Mar 19, 2024
Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof
DANA FARBER CANCER INST INC3 citations73
US11826365B2Nov 28, 2023
Type II raf kinase inhibitors
DANA FARBER CANCER INST INC1 citations73
US10981903B2Apr 20, 2021
Inhibitors of c-Jun-N-terminal kinase (JNK)
DANA FARBER CANCER INST INC4 citations73
US10913744B2Feb 9, 2021
LRRK2 inhibitors and methods of making and using the same
DANA FARBER CANCER INST INC3 citations73
US10695346B2Jun 30, 2020
4,6-pyrimidinylene derivatives and uses thereof
DANA FARBER CANCER INST INC5 citations73
US10342798B2Jul 9, 2019
Fused bicyclic pyrimidine derivatives and uses thereof
DANA FARBER CANCER INST INC7 citations73
US10081639B2Sep 25, 2018
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
DANA FARBER CANCER INST INC2 citations73
US9701683B2Jul 11, 2017
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
DANA FARBER CANCER INST INC2 citations73
IRM LLC
9 patentsUS7060697B2Jun 13, 2006
Immunosuppressant compounds and compositions
IRM LLC67 citations97
US7589101B2Sep 15, 2009
Compounds and compositions as protein kinase inhibitors
IRM LLC30 citations92
US7176312B2Feb 13, 2007
Kinase inhibitor scaffolds and methods for their preparation
IRM LLC25 citations92
US7868018B2Jan 11, 2011
Compounds and compositions as protein kinase inhibitors
IRM LLC11 citations84
US7713958B2May 11, 2010
Compounds and compositions as protein kinase inhibitors
IRM LLC8 citations84
US7449582B2Nov 11, 2008
Compounds and compositions as protein kinase inhibitors
IRM LLC15 citations83
US7151096B2Dec 19, 2006
Cyclic compounds and compositions as protein kinase inhibitors
IRM LLC15 citations82
US7169817B2Jan 30, 2007
Bis-aromatic alkanols
IRM LLC12 citations79
US7462629B2Dec 9, 2008
Immunosuppressant compounds and compositions
IRM LLC7 citations74
UNIV CALIFORNIA
4 patentsUS6255485B1Jul 3, 2001
Purine inhibitors of protein kinases, G proteins and polymerases
UNIV CALIFORNIA42 citations96
US6573044B1Jun 3, 2003
Methods of using chemical libraries to search for new kinase inhibitors
UNIV CALIFORNIA27 citations92
US6803371B2Oct 12, 2004
Purine inhibitors of protein kinases, G proteins and polymerases
UNIV CALIFORNIA7 citations73
US6617331B2Sep 9, 2003
Purine inhibitors of protein kinases, G proteins and polymerases
UNIV CALIFORNIA4 citations73
SCRIPPS RESEARCH INST
3 patentsUS6949644B2Sep 27, 2005
Methods for the synthesis of substituted purines
SCRIPPS RESEARCH INST21 citations93
US7253166B2Aug 7, 2007
6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells
SCRIPPS RESEARCH INST18 citations84
US7273864B2Sep 25, 2007
Compositions and methods for inducing osteogenesis
SCRIPPS RESEARCH INST9 citations74
GRAY NATHANAEL S
3 patentsUS9180127B2Nov 10, 2015
Type II Raf kinase inhibitors
GRAY NATHANAEL S24 citations89
US9908884B2Mar 6, 2018
EGFR inhibitors and methods of treating disorders
GRAY NATHANAEL S12 citations81
US9266890B2Feb 23, 2016
Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
GRAY NATHANAEL S7 citations78
BROAD INST INC
2 patentsNOVARTIS AG
1 patentGATEKEEPER PHARMACEUTICALS INC
1 patentShowing the top 50 of 141 patents by PatentIndex Score.